REGENXBIO (RGNX) SEC Filings & 10K Form

$16.19
+0.13 (+0.81%)
(As of 04/26/2024 ET)

Recent REGENXBIO SEC Filings

DateFilerForm TypeView
04/17/2024
4:05 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:11 PM
REGENXBIO (Filer)
Form DEF 14A
04/04/2024
3:15 PM
REGENXBIO (Filer)
Form DEFA14A
04/04/2024
3:20 PM
REGENXBIO (Filer)
Form ARS
03/21/2024
4:20 PM
REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 AM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
5:09 AM
REGENXBIO (Filer)
Form 424B5
03/07/2024
5:05 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:03 AM
REGENXBIO (Subject)
Form FWP
03/06/2024
3:23 PM
REGENXBIO (Filer)
Form 424B5
03/05/2024
3:26 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
5:28 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:13 PM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/05/2024
2:04 PM
GIC Private Ltd (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
10:10 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
10:11 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
6:16 AM
REGENXBIO (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/19/2024
1:40 PM
BlackRock Inc. (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/18/2024
5:39 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
3:22 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:22 PM
Danos Olivier (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:23 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:17 PM
REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:06 PM
Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
12:38 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:29 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
4:15 PM
Redmile Group, LLC (Filed by)
REGENXBIO (Subject)
Form SC 13G
11/08/2023
3:15 PM
REGENXBIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/01/2023
3:42 PM
REGENXBIO (Filer)
Form 424B5
09/01/2023
3:12 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2023
3:31 PM
REGENXBIO (Filer)
Form S-3ASR
06/06/2023
4:11 PM
REGENXBIO (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:11 PM
Bennett Jean (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:12 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:12 PM
Glucksmann Alexandra (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:12 PM
MIGAUSKY GEORGE V (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:12 PM
REGENXBIO (Issuer)
STUMP DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:13 PM
REGENXBIO (Issuer)
Tasse Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:14 PM
Fox Allan M. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
8:49 AM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
Protect Yourself While There’s Still Time … (Ad)

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.
05/03/2023
3:11 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RGNX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners